<?xml version="1.0" encoding="UTF-8"?>
<p>Lopinavir/ritonavir works by inhibiting the 3-chemotrypsin-like protease of SARS, MERS, and SARS-Cov-2. Observational studies (in SARS-CoV-2 and SARS) support the initiation of therapy in the first 7â€“10 days, otherwise the clinical benefits are not found in patients (
 <xref rid="B36" ref-type="bibr">36</xref>).
</p>
